MYC and colorectal carcinoma: In summary, FBX8 can ubiquitinate and degrade HIF-1α, CDK4 and C-Myc, and downregulate their ability to promote angiogenesis, cell cycle progression and cell proliferation, respectively, thereby regulating the dormancy of CRC liver metastasis cells.